Obesity is associated with more than 30 medical conditions including Type 2 Diabetes, Coronary Heart Disease, Osteroarthritis, High Blood Pressure, Breast Cancer, Cancers of the Esophagus and Gastric Cardia, Impaired Immune Response. Low Back Pain etc. Selim et al (2008) have shown that Obesity is related to reduced blood flow velocities in the middle cerebral arteries. Laasko et al (1990) has shown that reduced insulin-mediated glucose uptake in human obesity is due to defects in insulin’s action to increase blood flow to these tissues. Laasko et al report that this defect in insulin’s action is a novel mechanism of insulin resistance. Overall, obesity is characterized by decreased blood flow into muscle. The reduced blood flow and/or tissue activity can lead to decreased insulin-medicated glucose uptake, another factor associated with obesity according to Laasko et al (1990). Cheuk-Kwan Sun et al (2003) demosnstrated that obesity is related with reduced portal venus blood flow, and a decrease in overall hepatic perfusion and oxygenation.
A clinical study with individuals presenting abnormally clumped Red Blood Cells’ (RBCs) was completed in February 2009 with a device representing the Pacemaker Technology for the Skeletal muscle (PTSM / Ion Magnum – IM). Results (see figure 1) indicate that this technology rapidly and efficiently leads to normalized erythrocytes’ separation at the microscopic level. RBCs separation is crucial for the overall blood flow and timely transport of hormones, antibodies, oxygen and nutrients to the cells, and waste products to the kidneys. Transport of Hormones is a crucial process lipolysis (T3 and Growth Hormone — GF) and muscle hypertrophy (Insulin Growth Factor – IGF-1). Additionally, erythrocyte separation resulting from treatment with the Pacemaker technology for the skeletal muscle appears to have a negative correlation with the number of fungal forms, poikilocytosis, thrombocyte aggregation and bacteria present in the blood prior to the IM treatments, In summary, the erythrocyte separation resulting from treatments with the pacemaker technology for the skeletal muscle enhance hormonal transport including T3 and GH enhances hormonal transport including T3 and GH leading to lipolysis and muscle hypertrophy; 2) RBC;s separation enhances overall level of health by a significant reduction of free radicals. bacteria, fungal forms. etc.; 3) Obesity is characterized by reduced blood flow. PTSM increases RBC’s separation resulting in normalized blood flow. In conclusion, re-establishing normal levels of blood flow will not only help reduce obesity but it will help reduce the risk of heart attack as well as all other disorders associated with obesity.
The fact that the Pacemaker Technology for the Skeletal muscle reduces Obesity is shown in a recent clinical study 2009. Five separate clinics from around the world participated in this clinical study . All five subjects that participated in the study showed substantial weight loss, including reduction of visceral fat. Jensen (2008) reports that an upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. The before and after of subject 3 are shown in figure 2.
IM Research, the Pacemaker Technology, London University, UK Xanya Sofra-Weiss, Ph.D
The Pacemaker Technology for the Skeletal Muscle (PTSM) is a voltage driven device, very much like the Pacemaker. However, due to the complexity of the CNS, PTSM is based on a dynamic multi-sine, analogue waveform that was originally tested at the cellular level by Dr. Donald Gilbert, a molecular biologist, in the eighties. After 30 years of research, the IM was
electronically engineered by the Co-Inventor of the first Pacemaker (2008) to resonate the motor nerve’s signal of strenuous exercise normally emitted by the brain. Due to its resonance with the biological signal, the PTSM signal spreads throughout the CNS inducing effortless and painless isometric and isotonic muscle contractions. The signal to the nerve ultimately triggers hormonal secretion such as Growth Hormone (GF), Thyroxine (T4) and Triiodothyronine (T3) for lipolysis and Insulin Growth Factor (IGF-1) for muscle hypertrophy.